Research on Hypoglycemia Risk in Combination Therapy with Dipeptidyl Peptidase-4 Inhibitors and Other Oral Antidiabetes Medications in Patients with Diabetes Mellitus
碩士 === 中國醫藥大學 === 醫務管理學系碩士班 === 102 === Background and Object: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of drug that can be used for treating diabetes. However, whether administering DPP-4 inhibitors causes the side effect of hypoglycemia has not been determined. The objective of th...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/5rh588 |